Mode
Text Size
Log in / Sign up
N/A N=222 Randomized Supportive Care

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions

Sickle Cell Disease · Chronic Kidney Diseases · Systemic Lupus Erythematosus · Childhood Cancer · Inflammatory Bowel Diseases

Enrolled (actual)
222
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Change in Self-management as Measured by the Partners in Health Scale — 6.7; 6.5; 6.8; 6.6 score on a scale — p=0.0034

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PiCASO Intervention Group (Behavioral); Sham Comparator: Attention Control Group (Behavioral)
Age
Pediatric, Adult · 16+ yrs
Sex
All
Sponsor
Duke University
Primary completion
Jun 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Self-management as Measured by the Partners in Health Scale
6.7; 6.5; 6.8; 6.6; 6.9; 6.6 0.0034 sig
PRIMARY
Patient Activation as Measured by the Patient Activation Measure (PAM-13)
70.0; 68.8; 72.4; 70.8; 74.9; 72.8 0.5137
SECONDARY
Change in Transition Readiness as Measured by the Transition Readiness Questionnaire (TRAQ 20)
4.1; 3.9; 4.2; 4.0; 4.3; 4.1 0.4107
SECONDARY
Change in Health-related Quality of Life as Measured by the Short Form Health Survey (SF12) - Mental Component Summary (MCS)
45.5; 45.1; 46.1; 45.1; 46.7; 45.1 0.1708
SECONDARY
Change in Emotional Health as Measured by the Brief Symptom Inventory (BSI 18)
9.7; 10.7; 9.5; 10.5; 9.3; 10.4 0.7982

Summary

The purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood onset chronic conditions.

Eligibility Criteria

Inclusion Criteria

  • AYA 16 to 22 years
  • Childhood onset chronic condition from 1 of 3 condition categories
  • Read and speaks English
  • Access to internet via computer or Smart Phone
  • Access to telephone (Smart Phone not required as text feature can be accessed via internet)

Exclusion Criteria

  • Diagnosed cognitive dysfunction
  • Need for English translator
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03938324). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search